This prompted an unusual and bitter bidding war, where Doustdar goaded Pfizer to raise its bid during a press conference in the Oval Office. In the end, Pfizer won by matching Novo’s $10bn offer, as ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback